In an MPTP-induced PD mouse model, linagliptin regulated microglial polarization and the NLRP3 inflammasome signaling pathway, which led to attenuated neuroinflammation and thus resulted in neuroprotective effects [46]. This evidence concerns the gene NLRP3 and Parkinson disease.